L-745870 |
Antagonist of DRD4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DRD4 |
|
Antagonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Within Target family:
Selective against human D2 and D3 receptors with Ki 960 and 2300 nM respective ...
Potency Cellular
In Vitro
DRD4
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm9600712
In Vivo Validations
Rat
Dose: 3 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
2.1 h (plasma)
Cmax:
360 ng/mL (plasma), 5.1 ug/mL (brain)
Bioavailability:
66%
Organ of interest (O):
Brain
Target engagement assay:
Brain/Plasma ratio >10
ED50 3.0 mg/Kg in sigma assay
PMID Reference: 9353380
Dose: 1 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
2.8 h (plasma)
Cmax:
35 ng/mL (plasma)
Bioavailability:
20%
PMID Reference: 9353380
Chemical Information
| Molecular Formula | C18H19ClN4 |
| SMILEs | Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1 |
| InChI | InChI=1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21) |
| Molecular weight | 326.13 Da |
| AlogP | 3.5385000000000018 |
| HBond acceptors | 4 |
| HBond donors | 1 |
| Atoms | 42 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.